We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Risk of Harm from Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients Pre or Post Bariatric Surgery.
- Authors
Sharma, Mitesh; Nayar, Rahul; Graham, Yitka; Parretti, Helen M.; Abbott, Sally; Tahrani, Abd; Miras, Alexander D.; Madhok, Brijesh; Singhal, Rishi; Mahawar, Kamal
- Abstract
References 1 Iqbal QZ, Mishiyev D, Zia Z. Euglycemic diabetic ketoacidosis with sodium-glucose cotransporter-2 inhibitor use post-bariatric surgery: a brief review of the literature. 2016; 39: 50-53. 10.2337/dc15-2647 8 Lane S, Paskar D, Hamed S. When guidelines fail: euglycemic diabetic ketoacidosis after bariatric surgery in a patient taking a sodium-glucose cotransporter-2 inhibitor: a case report. Dear Editor, We would like to raise awareness amongst your readers of the potential harm associated with the use of sodium-glucose co-transporter-2 inhibitors (SGLT-2is) in patients undergoing bariatric and metabolic surgery (BMS).
- Subjects
BARIATRIC surgery; GASTRIC bypass; MORBID obesity; ACETONEMIA
- Publication
Obesity Surgery, 2022, Vol 32, Issue 7, p2469
- ISSN
0960-8923
- Publication type
Article
- DOI
10.1007/s11695-022-06044-6